Oncotarget Trending with Impact: Murine Model of Cancer-derived Myocardial Damage Researchers in this study employed one of the few available murine cachexia models and validated... read more February 18, 2021
Oncotarget Table of Contents: Oncotarget’s Volume 12, Issue #4 Read short summaries of the latest research literature published by Oncotarget.Origin: Maryland, Minnesota,&... read more February 16, 2021
Oncotarget Behind the Study: Statins Primary Mode of Action Against Cancer Cells Neuro-oncologist physician-scientist Dr. Benjamin Purow describes the findings in a paper he helped author in... read more February 15, 2021
Oncotarget Behind the Study: Critical Role STAT3 Plays in Glioma-initiating Cells The head chair of pathology and a graduate research assistant from the University of Tennessee... read more February 8, 2021
Oncotarget Behind the Study: Secretomes in Breast Cancer Cells Induce MSC Actions Researchers describe their paper published in Oncotarget titled, "Secretomes from metastatic breast cancer cells, enriched... read more January 11, 2021
Oncotarget Metabolism of Breast Cancer Cells Exploited by Amino Acids Researchers from Germany starved breast cancer cells of amino acids, including methionine, and exploited their... read more December 1, 2020
Oncotarget Can MEK Inhibitor Drugs Improve COVID-19? A promising new treatment option for the coronavirus was studied using a COVID-19 pseudovirus approach... read more November 17, 2020
Oncotarget Trending with Impact: Basal Cell Bladder Cancer and MEK Inhibitors For patients with basal cell bladder cancer, researchers in this study identify MEK inhibitors as... read more November 12, 2020